{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:48:13Z","timestamp":1771462093491,"version":"3.50.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbcan.2025.189415","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T22:27:33Z","timestamp":1754778453000},"page":"189415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of YY1 in pancreatic ductal adenocarcinoma: Mechanisms and therapeutic perspectives"],"prefix":"10.1016","volume":"1880","author":[{"given":"Pallavi","family":"Pellakuru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Guenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niharitha","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganji Purnachandra","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0005","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2198479","article-title":"Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence","volume":"24","author":"Adekolujo","year":"2023","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0010","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"Ca"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189415_bb0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pan.2024.06.004","article-title":"The impact of metastatic sites on survival rates and predictors of extended survival in patients with metastatic pancreatic cancer","volume":"24","author":"Levine","year":"2024","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0020","first-page":"1","article-title":"The role of TP53 and associated pathways in pancreatic ductal adenocarcinoma progression","volume":"15","author":"Mokhtari Tabar","year":"2025","journal-title":"J. Adv. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2025.189415_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.753456","article-title":"Deregulation of transcription factor networks driving cell plasticity and metastasis in pancreatic cancer","volume":"9","author":"van Roey","year":"2021","journal-title":"Front. Cell Develop. Biol."},{"issue":"23\u201324","key":"10.1016\/j.bbcan.2025.189415_bb0030","doi-asserted-by":"crossref","first-page":"2000034","DOI":"10.1002\/pmic.202000034","article-title":"Transcription factors: bridge between cell signaling and gene regulation","volume":"21","author":"Weidem\u00fcller","year":"2021","journal-title":"Proteomics"},{"key":"10.1016\/j.bbcan.2025.189415_bb0035","series-title":"YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target","author":"Bonavida","year":"2020"},{"key":"10.1016\/j.bbcan.2025.189415_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2017.08.032","article-title":"Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis","volume":"408","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189415_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116422","article-title":"The YY1-CPT1C signaling axis modulates the proliferation and metabolism of pancreatic tumor cells under hypoxia","volume":"227","author":"Zhou","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189415_bb0050","doi-asserted-by":"crossref","first-page":"e23581","DOI":"10.1096\/fj.202400166R","article-title":"The DDX6\/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer","volume":"38","author":"Deng","year":"2024","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189415_bb0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41388-021-02159-9","article-title":"A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189415_bb0060","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.eprac.2021.02.016","article-title":"Mutation and expression of gene YY1 in pancreatic neuroendocrine tumors and its clinical significance","volume":"27","author":"Song","year":"2021","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-017-0233-y","article-title":"The MiR-135b\u2013BMAL1\u2013YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189415_bb0070","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1073\/pnas.1503696112","article-title":"Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas","volume":"112","author":"Cromer","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189415_bb0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0043-107244","article-title":"T372R mutation status in Yin Yang 1 gene in Insulinoma patients","volume":"49","author":"Irshad","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0080","doi-asserted-by":"crossref","first-page":"E776","DOI":"10.1210\/jc.2015-1100","article-title":"Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas","volume":"100","author":"Lichtenauer","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0085","doi-asserted-by":"crossref","first-page":"L31","DOI":"10.1530\/ERC-17-0311","article-title":"Frequency and consequence of the recurrent YY1 p.T372R mutation in sporadic insulinomas","volume":"25","author":"Parekh","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189415_bb0090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/1873-3468.12106","article-title":"Significance of the pathogenic mutation T372R in the Yin Yang 1 protein interaction with DNA--thermodynamic studies","volume":"590","author":"Nieborak","year":"2016","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189415_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cells13100864","article-title":"Cross-talks between Raf kinase inhibitor protein and programmed cell death ligand 1 expressions in cancer: role in immune evasion and therapeutic implications","volume":"13","author":"Ho","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189415_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/pin.13410","article-title":"Yin Yang 1 facilitates the activation, inflammation, and extracellular matrix deposition of hepatic stellate cells in hepatic fibrosis","volume":"74","author":"Fu","year":"2024","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbcan.2025.189415_bb0105","article-title":"Dissecting the roles and clinical potential of YY1 in the tumor microenvironment","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189415_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00360552","article-title":"Chromosomal localization of the transcription factor YY1 in the mouse and human","volume":"5","author":"Zhu","year":"1994","journal-title":"Mamm. Genome"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189415_bb0115","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/nar\/26.16.3776","article-title":"Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1","volume":"26","author":"Yao","year":"1998","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189415_bb0120","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/MCB.21.17.5979-5991.2001","article-title":"Regulation of transcription factor YY1 by acetylation and deacetylation","volume":"21","author":"Yao","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"33","key":"10.1016\/j.bbcan.2025.189415_bb0125","doi-asserted-by":"crossref","first-page":"22614","DOI":"10.1074\/jbc.M114.567040","article-title":"Structure of yin Yang 1 oligomers that cooperate with RuvBL1-RuvBL2 ATPases","volume":"289","author":"L\u00f3pez-Perrote","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189415_bb0130","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1093\/nar\/23.21.4457","article-title":"DNA binding sites for the transcriptional activator\/repressor YY1","volume":"23","author":"Hyde-DeRuyscher","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2025.189415_bb0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/PL00000885","article-title":"Three classes of C2H2 zinc finger proteins","volume":"58","author":"Iuchi","year":"2001","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"51","key":"10.1016\/j.bbcan.2025.189415_bb0140","doi-asserted-by":"crossref","first-page":"19296","DOI":"10.1073\/pnas.0603564103","article-title":"Polycomb recruitment to DNA in vivo by the YY1 REPO domain","volume":"103","author":"Wilkinson","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0145","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jcb.22424","article-title":"PcG recruitment by the YY1 REPO domain can be mediated by Yaf2","volume":"109","author":"Wilkinson","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0150","first-page":"F49","article-title":"Everything you have ever wanted to know about Yin Yang 1","volume":"1332","author":"Shi","year":"1997","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189415_bb0155","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.7150\/thno.43481","article-title":"The biological implications of Yin Yang 1 in the hallmarks of cancer","volume":"10","author":"Meliala","year":"2020","journal-title":"Theranostics"},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2025.189415_bb0160","article-title":"Targeting the overexpressed YY1 in cancer inhibits EMT and metastasis","volume":"22","author":"Cho","year":"2017","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bbcan.2025.189415_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-11-472","article-title":"YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma","volume":"11","author":"de Nigris","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189415_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592164","article-title":"The why of YY1: mechanisms of transcriptional regulation by Yin Yang 1","volume":"8","author":"Verheul","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/trns.1.2.12375","article-title":"Yin Yang 1: a multifaceted protein beyond a transcription factor","volume":"1","author":"Deng","year":"2010","journal-title":"Transcription"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-1119(99)00261-9","article-title":"Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?","volume":"236","author":"Thomas","year":"1999","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189415_bb0185","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.3390\/cimb46080499","article-title":"Therapeutic application and structural features of adeno-associated virus vector","volume":"46","author":"Matsuzaka","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbrc.2005.07.150","article-title":"Nucleophosmin\/B23 regulates PCNA promoter through YY1","volume":"335","author":"Weng","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189415_bb0195","first-page":"7487","article-title":"Yin-yang 1 activates the c-myc promoter","volume":"13","author":"Riggs","year":"1993","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189415_bb0200","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1128\/jvi.70.11.7695-7705.1996","article-title":"A novel C\/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region","volume":"70","author":"Bauknecht","year":"1996","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0205","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1074\/jbc.272.3.1709","article-title":"Characterization of the transcriptional regulator YY1: the bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CBP)-binding protein","volume":"272","author":"Austen","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0210","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/jvi.69.3.1628-1636.1995","article-title":"Adenovirus E1A proteins interact with the cellular YY1 transcription factor","volume":"69","author":"Lewis","year":"1995","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189415_bb0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/j.1460-2075.1995.tb07058.x","article-title":"GATA1 and YY1 are developmental repressors of the human epsilon-globin gene","volume":"14","author":"Raich","year":"1995","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0220","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/JVI.77.5.2903-2914.2003","article-title":"Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator\/repressor role","volume":"77","author":"Weill","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7","article-title":"Histone deacetylases, transcriptional control, and cancer","volume":"184","author":"Cress","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0230","first-page":"128","article-title":"The nuclear factor YY1 participates in repression of the beta-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction","volume":"14","author":"Meier","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189415_bb0235","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/MCB.02020-06","article-title":"NF-\u03baB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059679","article-title":"PARP-1 and YY1 are important novel regulators of CXCL12 gene transcription in rat pancreatic beta cells","volume":"8","author":"Markovi\u0107","year":"2013","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.bbcan.2025.189415_bb0245","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.93.24.13571","article-title":"YY1 transcriptional initiator: protein interactions and association with a DNA site containing unpaired strands","volume":"93","author":"Usheva","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0250","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/aid.2012.0227","article-title":"Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses","volume":"29","author":"Barton","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189415_bb0255","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.onc.1209080","article-title":"Transcription factor YY1: structure, function, and therapeutic implications in cancer biology","volume":"25","author":"Gordon","year":"2006","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.bbcan.2025.189415_bb0260","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/MCB.21.17.5979-5991.2001","article-title":"Regulation of transcription factor YY1 by acetylation and deacetylation","volume":"21","author":"Yao","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"6445","key":"10.1016\/j.bbcan.2025.189415_bb0265","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/365462a0","article-title":"Interaction between transcription factors Spl and YY1","volume":"365","author":"Seto","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189415_bb0270","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00726-006-0482-z","article-title":"Molecular cloning of a structural homolog of YY1AP, a coactivator of the multifunctional transcription factor YY1","volume":"33","author":"Ohtomo","year":"2007","journal-title":"Amino Acids"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189415_bb0275","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gad.9.10.1188","article-title":"Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300","volume":"9","author":"Lee","year":"1995","journal-title":"Genes Dev."},{"issue":"44","key":"10.1016\/j.bbcan.2025.189415_bb0280","doi-asserted-by":"crossref","first-page":"28001","DOI":"10.1074\/jbc.272.44.28001","article-title":"Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family","volume":"272","author":"Yang","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189415_bb0285","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cell.2017.11.008","article-title":"YY1 is a structural regulator of enhancer-promoter loops","volume":"171","author":"Weintraub","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189415_bb0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2016.10.008","article-title":"A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6","volume":"77","author":"Lin","year":"2017","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pcn.13510","article-title":"YY1 (Yin-Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression","volume":"77","author":"Lu","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189415_bb0300","doi-asserted-by":"crossref","first-page":"2308031","DOI":"10.1002\/advs.202308031","article-title":"YY1 lactylation aggravates autoimmune uveitis by enhancing microglial functions via inflammatory genes","volume":"11","author":"Huang","year":"2024","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0305","first-page":"L1219","article-title":"Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages","volume":"292","author":"Joo","year":"2007","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.bbcan.2025.189415_bb0310","doi-asserted-by":"crossref","first-page":"1122110","DOI":"10.3389\/fonc.2023.1122110","article-title":"Dissecting the roles and clinical potential of YY1 in the tumor microenvironment","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1568009615666150131124200","article-title":"The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies","volume":"15","author":"Shi","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193340","article-title":"Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189415_bb0325","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/OTT.S66667","article-title":"Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas","volume":"7","author":"Luo","year":"2014","journal-title":"Onco Targets Ther"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189415_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133506","article-title":"Targeting transcription factor YY1 for Cancer treatment: current strategies and future directions","volume":"15","author":"Hosea","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189415_bb0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1479-5876-12-80","article-title":"Yin yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma","volume":"12","author":"Kang","year":"2014","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/07357900802210760","article-title":"YY1 over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels","volume":"27","author":"Baritaki","year":"2009","journal-title":"Cancer Investig."},{"issue":"33","key":"10.1016\/j.bbcan.2025.189415_bb0345","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0402283101","article-title":"YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress","volume":"101","author":"Gr\u00f6nroos","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189415_bb0350","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2004.06.004","article-title":"Yin Yang 1 is a negative regulator of p53","volume":"117","author":"Sui","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0355","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0360","doi-asserted-by":"crossref","first-page":"799","DOI":"10.32604\/or.2024.045356","article-title":"Targeting KRAS in pancreatic cancer","volume":"32","author":"Stickler","year":"2024","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0370","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","article-title":"Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7755","key":"10.1016\/j.bbcan.2025.189415_bb0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0380","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12935-022-02712-w","article-title":"YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration","volume":"22","author":"Li","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189415_bb0385","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2017.08.032","article-title":"Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis","volume":"408","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189415_bb0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.07.019","article-title":"YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER\/STAT3\/MMP2 signaling pathway","volume":"463","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"50","key":"10.1016\/j.bbcan.2025.189415_bb0395","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/onc.2013.277","article-title":"Fer kinase promotes breast cancer metastasis by regulating \u03b16- and \u03b21-integrin-dependent cell adhesion and anoikis resistance","volume":"32","author":"Ivanova","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189415_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.04.044","article-title":"Transcriptional repressor kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c","volume":"431","author":"Abisoye-Ogunniyan","year":"2018","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189415_bb0405","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1541-7786.MCR-13-0003-T","article-title":"Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis","volume":"11","author":"Ahn","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189415_bb0410","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/ol.2022.13577","article-title":"Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma","volume":"24","author":"Cao","year":"2022","journal-title":"Oncol. Lett."},{"issue":"49","key":"10.1016\/j.bbcan.2025.189415_bb0415","doi-asserted-by":"crossref","first-page":"18571","DOI":"10.1074\/jbc.REV119.007060","article-title":"Regulator of G-protein signaling (RGS) proteins as drug targets: progress and future potentials","volume":"294","author":"O'Brien","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189415_bb0420","doi-asserted-by":"crossref","first-page":"e23581","DOI":"10.1096\/fj.202400166R","article-title":"The DDX6\/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer","volume":"38","author":"Deng","year":"2024","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0425","doi-asserted-by":"crossref","first-page":"13352","DOI":"10.1080\/21655979.2022.2038900","article-title":"Yin Yang 1-induced activation of LINC01133 facilitates the progression of pancreatic cancer by sponging miR-199b-5p to upregulate myelin regulatory factor expression","volume":"13","author":"Yang","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0430","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12935-022-02712-w","article-title":"YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration","volume":"22","author":"Li","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189415_bb0435","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41416-019-0604-5","article-title":"YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38\/MAPK and PI3K\/AKT pathways","volume":"121","author":"Chen","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"3\u20134","key":"10.1016\/j.bbcan.2025.189415_bb0440","article-title":"Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects","volume":"16","author":"Atchison","year":"2011","journal-title":"Crit. Rev. Oncog."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0445","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20031637","article-title":"The BCR-ABL1 kinase bypasses selection for the expression of a pre\u2013B cell receptor in pre\u2013B acute lymphoblastic leukemia cells","volume":"199","author":"Klein","year":"2004","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0450","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14737140.2018.1412260","article-title":"Targeted therapies in non-small cell lung cancer: a focus on ALK\/ROS1 tyrosine kinase inhibitors","volume":"18","author":"Sgambato","year":"2018","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0455","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1573408019666230227101036","article-title":"HGF\/c-MET: a potential target for the treatment of various cancers","volume":"19","author":"Anitha","year":"2023","journal-title":"Curr. Enzym. Inhib."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189415_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216677","article-title":"Globally approved EGFR inhibitors: insights into their syntheses, target kinases, biological activities, receptor interactions, and metabolism","volume":"26","author":"Abourehab","year":"2021","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189415_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012708","article-title":"Clinical efficacies of FLT3 inhibitors in patients with acute myeloid leukemia","volume":"23","author":"Song","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0470","doi-asserted-by":"crossref","first-page":"753","DOI":"10.20892\/j.issn.2095-3941.2020.0024","article-title":"Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling","volume":"17","author":"Qin","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020295","article-title":"Mechanism underlying triple VEGFR inhibitor tivozanib-induced hypertension in mice model","volume":"16","author":"Alanazi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189415_bb0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.22159\/ajpcr.2022.v15i4.44143","article-title":"The translational possibility of targeting LncRNAs as a therapeutic strategy for idiopathic pulmonary fibrosis","volume":"15","author":"Yadav","year":"2022","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189415_bb0485","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.3390\/ijms23084408","article-title":"Synergistic anti-angiogenic effect of combined VEGFR kinase inhibitors, lenvatinib, and regorafenib: a therapeutic potential for breast cancer","volume":"23","author":"Bajbouj","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189415_bb0490","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/leu.2015.42","article-title":"Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1","volume":"29","author":"Zabriskie","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2025.189415_bb0495","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11899-019-00512-0","article-title":"Targeting BTK in CLL: beyond ibrutinib","volume":"14","author":"Bond","year":"2019","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.bbcan.2025.189415_bb0500","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11899-020-00596-z","article-title":"The next generation of JAK inhibitors: an update on fedratinib, momelotonib, and pacritinib","volume":"15","author":"Patel","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189415_bb0505","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1039\/D3MD00145H","article-title":"MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives","volume":"14","author":"Ram","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189415_bb0510","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-017-4385-3","article-title":"Cyclin-dependent kinase 4\/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib","volume":"166","author":"Kwapisz","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189415_bb0515","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1042\/CS20150149","article-title":"Cellular and molecular effects of the mTOR inhibitor everolimus","volume":"129","author":"Saran","year":"2015","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189415_bb0520","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"13","key":"10.1016\/j.bbcan.2025.189415_bb0525","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood.2020007233","article-title":"Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study","volume":"137","author":"Stein","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189415_bb0530","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","article-title":"The proteasome and proteasome inhibitors in multiple myeloma","volume":"36","author":"Gandolfi","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2025.189415_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105808","article-title":"Comparative safety and tolerability of approved PARP inhibitors in cancer: a systematic review and network meta-analysis","volume":"172","author":"Cai","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189415_bb0540","doi-asserted-by":"crossref","DOI":"10.1242\/dev.197319","article-title":"A lineage-specific requirement for YY1 polycomb group protein function in early T cell development","volume":"148","author":"Assump\u00e7\u00e3o","year":"2021","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155311","article-title":"YY1 is required for germinal center B cell development","volume":"11","author":"Banerjee","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0550","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10789","article-title":"YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity","volume":"7","author":"Hwang","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189415_bb0555","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.2000667","article-title":"Vitamin D3\u2013induced promotor dissociation of PU. 1 and YY1 results in Fc\u03b5RI reduction on dendritic cells in atopic dermatitis","volume":"206","author":"Herrmann","year":"2021","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189415_bb0560","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3892\/ijmm.2016.2526","article-title":"Upregulation of miRNA-155 expression by OxLDL in dendritic cells involves JAK1\/2 kinase and transcription factors YY1 and MYB","volume":"37","author":"Yan","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189415_bb0565","doi-asserted-by":"crossref","first-page":"150923","DOI":"10.1016\/j.soncn.2019.08.002","article-title":"Cancer and the immune system: the history and background of immunotherapy","author":"Abbott","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189415_bb0570","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189415_bb0575","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2008.03.012","article-title":"Yin-Yang 1 regulates effector cytokine gene expression and TH2 immune responses","volume":"122","author":"Guo","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189415_bb0580","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.isci.2018.03.009","article-title":"YY1 upregulates checkpoint receptors and downregulates type I cytokines in exhausted, chronically stimulated human T cells","volume":"2","author":"Balkhi","year":"2018","journal-title":"Iscience"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189415_bb0585","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189415_bb0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189415_bb0595","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2025.189415_bb0600","first-page":"1","article-title":"Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed\/relapsed after CART19\/20 therapy","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189415_bb0605","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nbt.4195","article-title":"Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo","volume":"36","author":"Rafiq","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2025.189415_bb0610","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189415_bb0615","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/07357900802210760","article-title":"YY1 over-expression in human brain gliomas and meningiomas correlates with TGF-\u03b21, IGF-1 and FGF-2 mRNA levels","volume":"27","author":"Baritaki","year":"2009","journal-title":"Cancer Investig."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2500157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X2500157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T21:18:19Z","timestamp":1758143899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X2500157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0304419X2500157X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189415","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of YY1 in pancreatic ductal adenocarcinoma: Mechanisms and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189415"}}